Literature DB >> 16930533

Identification of CXCR3 receptor agonists in combinatorial small-molecule libraries.

Ilana L Stroke1, Andrew G Cole, Srilatha Simhadri, Marc-Raleigh Brescia, Madhuri Desai, Joan J Zhang, J Robert Merritt, Kenneth C Appell, Ian Henderson, Maria L Webb.   

Abstract

In a high-throughput screen of four million compounds from combinatorial libraries for small-molecule modulators of the chemokine receptor CXCR3, two classes of receptor agonists, based on tetrahydroisoquinoline and piperidinyl diazepanone templates, were identified. Several of these compounds stimulated calcium flux in HEK293 cells expressing the recombinant human CXCR3 receptor with efficacies and kinetics similar to those of native ligand CXCL11/I-TAC and stimulated chemotaxis of activated human T-cells. The agonist small molecules also inhibited binding of another CXCR3 ligand, CXCL10/IP-10, to the receptor. The response to small-molecule agonists was inhibited by a CXCR3-specific small-molecule antagonist previously identified within the same combinatorial compound collection but structurally unrelated to the agonists. Remarkably, while other, non-amino acid substituents were present in the majority of the library compounds screened, the agonists from both classes contained a positively charged amino acid component, with preference for Arg>Lys, as well as a hydrophobic component.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930533     DOI: 10.1016/j.bbrc.2006.08.019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.

Authors:  Jeffrey S Smith; Lowell T Nicholson; Jutamas Suwanpradid; Rachel A Glenn; Nicole M Knape; Priya Alagesan; Jaimee N Gundry; Thomas S Wehrman; Amber Reck Atwater; Michael D Gunn; Amanda S MacLeod; Sudarshan Rajagopal
Journal:  Sci Signal       Date:  2018-11-06       Impact factor: 8.192

2.  Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.

Authors:  D J Scholten; M Canals; M Wijtmans; S de Munnik; P Nguyen; D Verzijl; I J P de Esch; H F Vischer; M J Smit; R Leurs
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation.

Authors:  Graeme O'Boyle; Christopher R J Fox; Hannah R Walden; Joseph D P Willet; Emily R Mavin; Dominic W Hine; Jeremy M Palmer; Catriona E Barker; Christopher A Lamb; Simi Ali; John A Kirby
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

Review 4.  Pharmacological modulation of chemokine receptor function.

Authors:  D J Scholten; M Canals; D Maussang; L Roumen; M J Smit; M Wijtmans; C de Graaf; H F Vischer; R Leurs
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

5.  Identification and profiling of CXCR3-CXCR4 chemokine receptor heteromer complexes.

Authors:  A O Watts; M M H van Lipzig; W C Jaeger; R M Seeber; M van Zwam; J Vinet; M M C van der Lee; M Siderius; G J R Zaman; H W G M Boddeke; M J Smit; K D G Pfleger; R Leurs; H F Vischer
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

6.  Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.

Authors:  Emma L Wise; Cécile Duchesnes; Paula C A da Fonseca; Rodger A Allen; Timothy J Williams; James E Pease
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

7.  Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3.

Authors:  Belinda Nedjai; Hubert Li; Ilana L Stroke; Emma L Wise; Maria L Webb; J Robert Merritt; Ian Henderson; Anthony E Klon; Andrew G Cole; Richard Horuk; Nagarajan Vaidehi; James E Pease
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR).

Authors:  K Boyé; C Billottet; N Pujol; I D Alves; A Bikfalvi
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.